152 related articles for article (PubMed ID: 9065651)
1. Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.
Jahnke V; Strange R; Matthias C; Fryer A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S147-9. PubMed ID: 9065651
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
3. [Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma].
Jahnke V; Strange R; Matthias C; Fryer AA
Laryngorhinootologie; 1995 Nov; 74(11):691-4. PubMed ID: 8561822
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx.
Jahnke V; Matthias C; Fryer A; Strange R
Am J Surg; 1996 Dec; 172(6):671-3. PubMed ID: 8988674
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
6. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas.
Matthias C; Bockmühl U; Jahnke V; Harries LW; Wolf CR; Jones PW; Alldersea J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Feb; 8(1):1-6. PubMed ID: 9511175
[TBL] [Abstract][Full Text] [Related]
7. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking.
Warwick A; Sarhanis P; Redman C; Pemble S; Taylor JB; Ketterer B; Jones P; Alldersea J; Gilford J; Yengi L
Carcinogenesis; 1994 Dec; 15(12):2841-5. PubMed ID: 8001244
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis.
Matthias C; Jahnke V; Jones PW; Hoban PR; Alldersea JE; Worrall SF; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):815-23. PubMed ID: 10498401
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.
Luo YP; Chen HC; Khan MA; Chen FZ; Wan XX; Tan B; Ou-Yang FD; Zhang DZ
Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.
Lourenço GJ; Silva EF; Rinck-Junior JA; Chone CT; Lima CS
Tumour Biol; 2011 Dec; 32(6):1209-15. PubMed ID: 21870186
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6.
Worrall SF; Corrigan M; High A; Starr D; Matthias C; Wolf CR; Jones PW; Hand P; Gilford J; Farrell WE; Hoban P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Oct; 8(5):433-9. PubMed ID: 9825835
[TBL] [Abstract][Full Text] [Related]
17. Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk.
Acar H; Ozturk K; Muslumanoglu MH; Yildirim MS; Cora T; Cilingir O; Ozer B
Cancer Genet Cytogenet; 2006 Sep; 169(2):89-93. PubMed ID: 16938565
[TBL] [Abstract][Full Text] [Related]
18. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
[TBL] [Abstract][Full Text] [Related]
20. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
Lear JT; Smith AG; Bowers B; Heagearty AH; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
J Invest Dermatol; 1997 Apr; 108(4):519-22. PubMed ID: 9077484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
